Search

everythinglearnresearchcommunity

for

Search:↓

A new gel form of minoxidil is equally effective for hair growth and safer for the heart and other organs than the traditional solution.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Oxymetazoline cream 1.0% effectively reduces rosacea redness, and using baseline photos improves assessment accuracy.

The new compound may be a safer alternative to finasteride for prostate protection.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

RORA plays a key role in controlling seasonal hair molting by affecting hair follicle cell activity.

Retinol acetate can reduce the harmful effects of the drug benoxaprofen on white blood cells.

RXRα is crucial for proper immune response and links diet to immune function.

The compound 4c showed strong potential as an anticancer agent.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Minoxidil might partially activate estrogen receptors, affecting hair growth.

LLPS is crucial for RALF signaling, aiding plant growth and stress resilience.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Ruxolitinib cream may help treat severe hair loss in children.

4-(Ethoxycarbophenyl) retinamide is much less toxic than other retinoids.

Hyaluronic acid microneedles help deliver minoxidil derivatives effectively for hair regrowth.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Minoxidil prevents serotonin loss from MDMA by affecting potassium channels and increasing Akt phosphorylation.

Ruxolitinib can cause a delayed skin reaction on the nose.

GI197111X is best dissolved in Capmul MCM for trials.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

RXR agonists may promote hair growth in humans.